Dr. Beth Carlson, M.D

NPI: 1366443392
Total Payments
$3,387
2019 Payments
$15.26
Companies
32
Transactions
232
Medicare Patients
1,980
Medicare Billing
$171,443

Payment Breakdown by Category

Food & Beverage$3,381 (99.8%)
Education$6.02 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,381 231 99.8%
Education $6.02 1 0.2%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $503.23 36 $0 (2018)
AstraZeneca Pharmaceuticals LP $494.57 28 $0 (2018)
Amgen Inc. $335.91 16 $0 (2018)
SANOFI-AVENTIS U.S. LLC $302.61 18 $0 (2018)
Boehringer Ingelheim Pharmaceuticals, Inc. $237.91 16 $0 (2018)
Lilly USA, LLC $231.63 18 $0 (2018)
GlaxoSmithKline, LLC. $204.75 15 $0 (2018)
Janssen Pharmaceuticals, Inc $186.87 14 $0 (2018)
Merck Sharp & Dohme Corporation $117.70 9 $0 (2018)
Takeda Pharmaceuticals America, Inc. $94.50 10 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2019 $15.26 1 Kowa Pharmaceuticals America, Inc. ($15.26)
2018 $1,612 108 Novo Nordisk Inc ($267.66)
2017 $1,760 123 AstraZeneca Pharmaceuticals LP ($248.59)

All Payment Transactions

232 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
08/16/2019 Kowa Pharmaceuticals America, Inc. Livalo (Drug), Bystolic Food and Beverage Cash or cash equivalent $15.26 General
Category: Cardiovascular
12/18/2018 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Food and Beverage In-kind items and services $10.82 General
Category: Central Nervous System (CNS)
12/13/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.43 General
Category: Cardiovascular and Metabolism
12/10/2018 Merck Sharp & Dohme Corporation JANUVIA (Drug), JANUMET XR, STEGLATRO Food and Beverage In-kind items and services $15.98 General
Category: ENDOCRINOLOGY
11/29/2018 ARBOR PHARMACEUTICALS, INC. Edarbyclor (Drug) Food and Beverage In-kind items and services $15.24 General
Category: Cardiology/Vascular Diseases
11/08/2018 Amgen Inc. Prolia (Biological), Repatha Food and Beverage In-kind items and services $24.68 General
Category: Endocrinology
11/05/2018 Novo Nordisk Inc Victoza (Drug), Tresiba, Xultophy 100/3.6 Food and Beverage In-kind items and services $19.27 General
Category: Diabetes
11/01/2018 Bausch Health US, LLC MIGRANAL (Drug) Food and Beverage In-kind items and services $11.42 General
Category: NEUROLOGY
10/30/2018 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Food and Beverage In-kind items and services $10.86 General
Category: Central Nervous System (CNS)
10/29/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $15.49 General
Category: Cardiovascular & Metabolism
10/22/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $18.04 General
Category: Cardiovascular and Metabolism
10/18/2018 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $13.65 General
Category: RESPIRATORY
10/16/2018 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug), GLYXAMBI Food and Beverage In-kind items and services $12.61 General
Category: DIABETES
10/12/2018 Novo Nordisk Inc Saxenda (Drug) Food and Beverage In-kind items and services $11.06 General
Category: Obesity
10/08/2018 Amgen Inc. Aimovig (Biological), Repatha Food and Beverage In-kind items and services $20.42 General
Category: Neuroscience
10/04/2018 Lilly USA, LLC TRULICITY (Drug), JARDIANCE, BASAGLAR Food and Beverage In-kind items and services $15.55 General
Category: Diabetes
09/28/2018 Novo Nordisk Inc Victoza (Drug), Tresiba, Xultophy 100/3.6 Food and Beverage In-kind items and services $19.35 General
Category: Diabetes
09/24/2018 SANOFI-AVENTIS U.S. LLC SOLIQUA (Drug) Food and Beverage In-kind items and services $16.16 General
Category: DIABETES
09/20/2018 Eisai Inc. Belviq (Drug) Food and Beverage Cash or cash equivalent $12.58 General
Category: Nutrition and Weight Loss
09/01/2018 Bausch Health US, LLC MIGRANAL (Drug) Food and Beverage In-kind items and services $16.67 General
Category: NEUROLOGY
08/30/2018 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $14.38 General
Category: DIABETES
08/28/2018 GlaxoSmithKline, LLC. ANORO (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $16.94 General
Category: RESPIRATORY
08/27/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug), INVOKANA Food and Beverage In-kind items and services $13.37 General
Category: Cardiovascular & Metabolism
08/24/2018 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $11.33 General
Category: RESPIRATORY
08/23/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $13.66 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 147 207 $57,006 $16,426
2022 8 487 676 $125,309 $48,248
2021 13 667 940 $150,386 $58,111
2020 13 679 972 $146,283 $48,659
Total Patients
1,980
Total Services
2,795
Medicare Billing
$171,443
Procedure Codes
37

All Medicare Procedures & Services

37 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 70 107 $33,170 $9,226 27.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 60 83 $18,260 $5,123 28.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 17 17 $5,576 $2,076 37.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 167 324 $76,362 $26,141 34.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 101 101 $24,745 $12,957 52.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 72 92 $14,710 $4,766 32.4%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2022 33 34 $3,440 $2,314 67.3%
G0008 Administration of influenza virus vaccine Office 2022 40 41 $2,296 $1,150 50.1%
83036 Hemoglobin a1c level Office 2022 45 53 $2,809 $512.95 18.3%
G0009 Administration of pneumococcal vaccine Office 2022 13 13 $767.00 $366.22 47.7%
81003 Automated urinalysis test Office 2022 16 18 $180.00 $39.96 22.2%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 169 334 $77,822 $26,894 34.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 111 111 $27,195 $14,472 53.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 48 60 $9,480 $3,524 37.2%
90694 Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage Office 2021 41 41 $3,444 $2,724 79.1%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2021 14 14 $5,012 $2,323 46.3%
83036 Hemoglobin a1c level Office 2021 147 230 $9,526 $2,233 23.4%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 14 19 $5,928 $2,205 37.2%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 13 16 $2,800 $1,103 39.4%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 11 11 $3,938 $911.35 23.1%
G0008 Administration of influenza virus vaccine Office 2021 50 50 $2,800 $812.85 29.0%
87635 Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2021 14 14 $1,106 $718.34 64.9%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 17 17 $1,105 $139.20 12.6%
81003 Automated urinalysis test Office 2021 18 23 $230.00 $51.75 22.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 155 331 $77,123 $22,813 29.6%

About Dr. Beth Carlson, M.D

Dr. Beth Carlson, M.D is a Family Medicine healthcare provider based in Matthews, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1366443392.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beth Carlson, M.D has received a total of $3,387 in payments from pharmaceutical and medical device companies, with $15.26 received in 2019. These payments were reported across 232 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,381).

As a Medicare-enrolled provider, Carlson has provided services to 1,980 Medicare beneficiaries, totaling 2,795 services with total Medicare billing of $171,443. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Other Specialties Family Medicine
  • Location Matthews, NC
  • Active Since 08/01/2005
  • Last Updated 10/25/2020
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1366443392

Products in Payments

  • Victoza (Drug) $280.52
  • FARXIGA (Drug) $245.67
  • JARDIANCE (Drug) $160.14
  • Repatha (Biological) $159.96
  • Prolia (Biological) $155.53
  • SYMBICORT (Drug) $140.97
  • TRADJENTA (Drug) $132.97
  • TOUJEO (Drug) $130.13
  • PRALUENT (Drug) $124.50
  • Saxenda (Drug) $120.56
  • ANORO (Drug) $119.87
  • TRULICITY (Drug) $115.97
  • Trintellix (Drug) $103.35
  • INVOKANA (Drug) $99.11
  • BYDUREON (Drug) $94.48
  • XARELTO (Drug) $81.74
  • Belviq (Drug) $72.79
  • Livalo (Drug) $51.62
  • JANUVIA (Drug) $51.34
  • SOLIQUA (Drug) $47.98

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Matthews